Roche Holding AG Participation (ROG)

Switzerland
Currency in CHF
Disclaimer
250.95
+4.65(+1.89%)
Closed
Day's Range
246.35252.20
52 wk Range
231.05310.25
Bid/Ask
250.95 / 251.00
Prev. Close
246.3
Open
248.25
Day's Range
246.35-252.2
52 wk Range
231.05-310.25
Volume
1,771,864
Average Vol. (3m)
1,325,098
1-Year Change
-20.1%
Shares Outstanding
798,651,667
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
308.50
Upside +22.93%

People Also Watch

1,933.20
HRMS
+0.82%
99.62
NESN
-0.35%
85.06
NOVN
-1.25%
713.20
LVMH
+2.08%
24.34
UBSG
-1.82%
How do you feel today about ROG?
Vote to see community's results!
or

Roche Holding AG Participation Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD); and strategic agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize zilebesiran. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

Employees
103613